Purchases and Sales Made in Q4 2022 in Akero Therapeutics, Inc. (AKRO)
This table provides information about the institutional ownership of Akero Therapeutics, Inc. (AKRO) during Q4 2022. The information is specifically focused on institutions that hold shares of Akero Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2023
Q4 2022
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-935K- 21.88% |
$31.3M - $51.3M
|
3.34M
$99.2M
|
|
|
Feb 07, 2023
Q4 2022
|
Skorpios Trust
|
SELL
|
- |
-1.64M- 33.33% |
$54.7M - $89.7M
|
3.27M
$97.2M
|
|
|
Feb 13, 2023
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-1.93M- 91.23% |
$64.6M - $106M
|
186K
$5.52M
|
|
|
May 14, 2024
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-1.93M- 91.23% |
$64.6M - $106M
|
186K
$5.52M
|